• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSL1700037 甘精胰岛素利司那肽注射液 insulin glargine;lixisenatide Injection Biological Products Import Drug Application 2017-07-19 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd Certificate Issued 2018-08-07 view
JXSL1700044 甘精胰岛素利司那肽注射液 insulin glargine;lixisenatide Injection Biological Products Import Drug Application 2017-08-10 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd Certificate Issued 2018-08-07 view
JXSL1700045 甘精胰岛素利司那肽注射液 insulin glargine;lixisenatide Injection Biological Products Import Drug Application 2017-08-10 赛诺菲(中国)投资有限公司 Sanofi (China) Investment Co Ltd Certificate Issued 2018-08-07 view
JXSS2101024 甘精胰岛素利司那肽注射液1:1 insulin glargine;lixisenatide Injection Biological Products(3.1) Import Drug Application 2021-09-29 view
JXSS2101025 甘精胰岛素利司那肽注射液2:1 insulin glargine;lixisenatide Injection Biological Products(3.1) Import Drug Application 2021-09-30 view
JXSL2101132 甘精胰岛素利司那肽注射液2:1 insulin glargine;lixisenatide Injection Biological Products(3.1) Import Drug Application 2021-11-17 view
JXSL2101131 甘精胰岛素利司那肽注射液1:1 insulin glargine;lixisenatide Injection Biological Products(3.1) Import Drug Application 2021-11-17 view
JYSB2300196 甘精胰岛素利司那肽注射液(Ⅱ) insulin glargine;lixisenatide Injection Biological Products(3.1) Supplementary Application 2023-11-11 view
JYSB2400099 甘精胰岛素利司那肽注射液(Ⅰ) insulin glargine;lixisenatide Injection Biological Products Supplementary Application 2024-05-06 view
JYSB2400100 甘精胰岛素利司那肽注射液(Ⅱ) insulin glargine;lixisenatide Injection Biological Products Supplementary Application 2024-05-06 view
JYSB2400173 甘精胰岛素利司那肽注射液(Ⅰ) insulin glargine;lixisenatide Injection Biological Products Supplementary Application 2024-08-09 view
JYSB2400174 甘精胰岛素利司那肽注射液(Ⅱ) insulin glargine;lixisenatide Injection Biological Products Supplementary Application 2024-08-09 view